Recruiting studies: Anticoagulant Adverse Reaction

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Can Patients With Atrial Fibrillation Safely Discontinue Anticoagulant Therapy After Cardiac Surgery? (ATLAAC)
Phase 4 · 6 location(s) · Odense University Hospital · NCT06401616 Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP)
NA · 1 location(s) · Clinique Pasteur · NCT03297281 Clinical Trial to Evaluate Efficacy and Safety of Rivaroxaban 15mg and 20mg in Patients With Non-valvular Atrial Fibrill
Phase 4 · 1 location(s) · Korea University Anam Hospital · NCT06187311 Ultrasound Evaluation of Hematoma Risk After Needle EMG in Patient on DOAC Therapy
Phase N/A · 2 location(s) · Masaryk University · NCT07166302 COOLEY- Study: aCute On chrOnic Liver failurE Using the cYtosorb Device
NA · 1 location(s) · University Hospital, Antwerp · NCT06079021 Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation
Phase 4 · 1 location(s) · China National Center for Cardiovascular Diseases · NCT06108414 The Clinical Influence of Developing a Sustainable Cardiac Surgery Service to Reduce the Burden of Rheumatic Heart Disea
Phase N/A · 4 location(s) · Helse Nord-Trøndelag HF · NCT04556188

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.